Alan D Marmorstein Selected Research

Vitelliform Macular Dystrophy

3/2017	Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States.
1/2015	Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium.
4/2014	Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1.
12/2013	Differential effects of Best disease causing missense mutations on bestrophin-1 trafficking.
3/2010	Suppression of Ca2+ signaling in a mouse model of Best disease.
5/2006	The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1).
2/2006	Hydrodynamic properties of porcine bestrophin-1 in Triton X-100.
10/2004	A model of best vitelliform macular dystrophy in rats.
8/2003	Expression and localization of bestrophin during normal mouse development.
11/2002	Noninvasive recording and response characteristics of the rat dc-electroretinogram.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan D Marmorstein Research Topics

Disease

10	Vitelliform Macular Dystrophy 03/2017 - 11/2002
5	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 07/2002
3	Bestrophinopathy 01/2018 - 04/2014
2	Hemorrhage 01/2022 - 03/2006
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 04/2014 - 12/2005
2	Vitreoretinochoroidopathy 04/2014 - 05/2006
1	Prolapse 01/2022
1	Pica (Geophagia) 01/2020
1	Plexiform Neurofibroma 01/2017
1	Retinal Diseases 01/2017
1	Macular Edema 07/2016
1	Hyperthermia 01/2012
1	Hypohidrosis 01/2012
1	Retinal Detachment (Retinal Detachments) 03/2010
1	Glaucoma 02/2010
1	Eye Diseases (Eye Disease) 04/2008
1	Rupture 03/2006
1	Aneurysm (Aneurysms) 03/2006
1	Emphysema 03/2006

Drug/Important Bio-Agent (IBA)

12	BestrophinsIBA 01/2018 - 08/2003
7	Retinaldehyde (Retinal)IBA 01/2022 - 11/2002
4	Retinal Pigments (Pigments, Visual)IBA 01/2018 - 10/2004
3	Proteins (Proteins, Gene)FDA Link 12/2005 - 08/2003
2	AnionsIBA 01/2018 - 07/2015
2	LipofuscinIBA 03/2010 - 07/2002
1	AZD 6244IBA 01/2017
1	Acetazolamide (Diamox)FDA LinkGeneric 07/2016
1	AntibodiesIBA 05/2015
1	Pharmaceutical PreparationsIBA 01/2012
1	Glycoproteins (Glycoprotein)IBA 01/2012
1	4-O-carboxymethylascochlorinIBA 03/2010
1	fibulinIBA 03/2006
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2006

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2010
1	Transplantation 01/2020
1	Cell Transplantation 01/2018